Erin N. Howe

2.5k total citations
23 papers, 2.0k citations indexed

About

Erin N. Howe is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Erin N. Howe has authored 23 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Erin N. Howe's work include MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (7 papers) and Cancer Cells and Metastasis (5 papers). Erin N. Howe is often cited by papers focused on MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (7 papers) and Cancer Cells and Metastasis (5 papers). Erin N. Howe collaborates with scholars based in United States and Chile. Erin N. Howe's co-authors include Jennifer K. Richer, Dawn R. Cochrane, Nicole S. Spoelstra, Diana M. Cittelly, Steven K. Nordeen, Britta M. Jacobsen, Annie Jean, Anthony Elias, Ann D. Thor and Susan M. Edgerton and has published in prestigious journals such as Cell, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Erin N. Howe

23 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin N. Howe United States 19 1.3k 1.1k 616 288 259 23 2.0k
David Petillo United States 22 1.6k 1.2× 783 0.7× 460 0.7× 677 2.4× 172 0.7× 34 2.2k
Frédérique Spyratos France 24 878 0.7× 788 0.7× 660 1.1× 204 0.7× 280 1.1× 41 1.7k
Paul Meltzer United States 7 1.8k 1.3× 824 0.7× 768 1.2× 235 0.8× 206 0.8× 10 2.4k
Sofia K. Gruvberger-Saal Sweden 20 1.3k 1.0× 1.0k 0.9× 1.3k 2.0× 442 1.5× 357 1.4× 28 2.4k
Anna B. Glinskii United States 18 1.5k 1.1× 583 0.5× 694 1.1× 408 1.4× 163 0.6× 22 2.2k
Douglas S. Micalizzi United States 14 1.6k 1.2× 841 0.7× 1.2k 1.9× 293 1.0× 125 0.5× 25 2.4k
Panthea Taghavi Netherlands 6 1.3k 1.0× 1.2k 1.1× 405 0.7× 126 0.4× 166 0.6× 7 1.9k
Karen G. Montgomery Australia 15 1.1k 0.9× 362 0.3× 528 0.9× 397 1.4× 130 0.5× 17 1.6k
Peter Kabos United States 31 1.0k 0.8× 740 0.7× 1.5k 2.4× 828 2.9× 393 1.5× 100 2.5k
Hae‐Ock Lee South Korea 20 1.5k 1.1× 854 0.8× 759 1.2× 230 0.8× 100 0.4× 44 2.1k

Countries citing papers authored by Erin N. Howe

Since Specialization
Citations

This map shows the geographic impact of Erin N. Howe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin N. Howe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin N. Howe more than expected).

Fields of papers citing papers by Erin N. Howe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin N. Howe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin N. Howe. The network helps show where Erin N. Howe may publish in the future.

Co-authorship network of co-authors of Erin N. Howe

This figure shows the co-authorship network connecting the top 25 collaborators of Erin N. Howe. A scholar is included among the top collaborators of Erin N. Howe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin N. Howe. Erin N. Howe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palakurthi, Bhavana, Ian H. Guldner, Xiyu Liu, et al.. (2023). Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer. Nature Communications. 14(1). 2109–2109. 30 indexed citations
2.
Bahçecioğlu, Gökhan, Xiaoshan Yue, Erin N. Howe, et al.. (2021). Aged Breast Extracellular Matrix Drives Mammary Epithelial Cells to an Invasive and Cancer‐Like Phenotype. Advanced Science. 8(22). e2100128–e2100128. 34 indexed citations
3.
Howe, Erin N., Victoria Hedrick, James Clancy, et al.. (2020). Rab11b-mediated integrin recycling promotes brain metastatic adaptation and outgrowth. Nature Communications. 11(1). 3017–3017. 44 indexed citations
4.
Guldner, Ian H., Qingfei Wang, Lin Yang, et al.. (2020). CNS-Native Myeloid Cells Drive Immune Suppression in the Brain Metastatic Niche through Cxcl10. Cell. 183(5). 1234–1248.e25. 110 indexed citations
5.
Guldner, Ian H., Lan Jiang, Longhua Sun, et al.. (2019). Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer. Nature Communications. 10(1). 2860–2860. 17 indexed citations
6.
Guldner, Ian H., et al.. (2017). GAD1 Upregulation Programs Aggressive Features of Cancer Cell Metabolism in the Brain Metastatic Microenvironment. Cancer Research. 77(11). 2844–2856. 37 indexed citations
7.
Zellmer, Victoria R., et al.. (2017). Tumor-induced Stromal STAT1 Accelerates Breast Cancer via Deregulating Tissue Homeostasis. Molecular Cancer Research. 15(5). 585–597. 21 indexed citations
8.
Wahdan-Alaswad, Reema S., Dawn R. Cochrane, Nicole S. Spoelstra, et al.. (2014). Metformin-Induced Killing of Triple-Negative Breast Cancer Cells Is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b. Hormones and Cancer. 5(6). 374–389. 86 indexed citations
9.
Cittelly, Diana M., Irina Dimitrova, Erin N. Howe, et al.. (2012). Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel. Molecular Cancer Therapeutics. 11(12). 2556–2565. 104 indexed citations
10.
Howe, Erin N., Dawn R. Cochrane, & Jennifer K. Richer. (2012). The miR-200 and miR-221/222 microRNA Families: Opposing Effects on Epithelial Identity. Journal of Mammary Gland Biology and Neoplasia. 17(1). 65–77. 107 indexed citations
11.
Howe, Erin N., Dawn R. Cochrane, Diana M. Cittelly, & Jennifer K. Richer. (2012). miR-200c Targets a NF-κB Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer. PLoS ONE. 7(11). e49987–e49987. 69 indexed citations
12.
Cochrane, Dawn R., et al.. (2012). Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer. Molecular and Cellular Endocrinology. 355(1). 15–24. 50 indexed citations
13.
Cittelly, Diana M., Jessica Finlay-Schultz, Erin N. Howe, et al.. (2012). Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. Oncogene. 32(20). 2555–2564. 110 indexed citations
14.
Elias, Anthony, Dawn R. Cochrane, Britta M. Jacobsen, et al.. (2012). Effect of MDV3100, an androgen receptor signaling inhibitor, on tumor growth of estrogen and androgen receptor-positive (ER+/AR+) breast cancer xenografts.. Journal of Clinical Oncology. 30(15_suppl). 564–564. 2 indexed citations
15.
Howe, Erin N., Dawn R. Cochrane, & Jennifer K. Richer. (2011). Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Research. 13(2). R45–R45. 205 indexed citations
16.
Richer, Jennifer K., Erin N. Howe, & Dawn R. Cochrane. (2011). Abstract 137: MicroRNA-200c restores anoikis sensitivity in breast and gynecological cancers. Cancer Research. 71(8_Supplement). 137–137. 3 indexed citations
17.
Cochrane, Dawn R., Diana M. Cittelly, Erin N. Howe, et al.. (2010). MicroRNAs Link Estrogen Receptor Alpha Status and Dicer Levels in Breast Cancer. Hormones and Cancer. 1(6). 306–319. 108 indexed citations
18.
Cochrane, Dawn R., Nicole S. Spoelstra, Erin N. Howe, Steven K. Nordeen, & Jennifer K. Richer. (2009). MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Molecular Cancer Therapeutics. 8(5). 1055–1066. 261 indexed citations
19.
Cochrane, Dawn R., Erin N. Howe, Nicole S. Spoelstra, & Jennifer K. Richer. (2009). Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers. Journal of Oncology. 2010. 1–12. 141 indexed citations
20.
Singh, Meenakshi, Nicole S. Spoelstra, Annie Jean, et al.. (2008). ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease. Modern Pathology. 21(7). 912–923. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Petillo Breakdown of academic impact, for papers by Frédérique Spyratos Breakdown of academic impact, for papers by Paul Meltzer Breakdown of academic impact, for papers by Sofia K. Gruvberger-Saal Breakdown of academic impact, for papers by Anna B. Glinskii Breakdown of academic impact, for papers by Douglas S. Micalizzi Breakdown of academic impact, for papers by Panthea Taghavi Breakdown of academic impact, for papers by Karen G. Montgomery Breakdown of academic impact, for papers by Peter Kabos Breakdown of academic impact, for papers by Hae‐Ock Lee
Rankless by CCL
2026